Objectives-Pulmonary disease is responsible for considerable morbidity and mortality in systemic sclerosis (SSc). Static lung compliance (Cst) has been observed to be decreased more often in SSc than the vital capacity, indicating that it is a sensitive measure of lung restriction. In this study Cst was compared with the carbon monoxide transfer factor (TLCO), a widely used measure of the function of the alveolar capillary unit, and with lung volumes in 59 patients with confirmed or suspected SSc. Methods-Cst was calculated from the oesophageal pressure at different lung volumes and the TLCO was measured with the single breath method. Results-The TLCO was found to be the earliest sign ofpulmonary disease and was already decreased at a disease duration of one year or less. Surprisingly, no relation was found between the TLCO and smoking habits, nor the degree of peripheral vascular disease. The TLCO correlated with the Cst and vital capacity. Conclusions-An early pulmonary lesion can be identified in patients with SSc with decreased TLCO at a time when no fibrotic changes are manifested.
Pulmonary disease contributes considerably to morbidity and mortality in patients with systemic sclerosis (SSc).' The interstitial disease in SSc has generally been considered as a relatively 'pure' fibrotic disorder, but several studies with bronchoalveolar lavage, [2] [3] [4] [5] [6] gallium-67 scanning,5 7 8 and open lung biopsy6 8 have shown the presence of alveolitis. A variety of lung function tests have been applied for the detection of pulmonary disease in SSc. Techniques reflecting the mechanics of breathing-for example, measurements of static lung volumes and lung compliance-are commonly used, but also techniques reflecting the functional integrity of the gas exchanging region of the lung, such as the measurement of the carbon monoxide transfer factor (TLCO). Decreased TLCO is reported to be an early sign of pulmonary disease in SSc,9-12 whereas other workers have found that the TLCO is rarely the only abnormality in SSc. '3 14 Static lung compliance (Cst) has been reported to be the most Isensitive parameter for the detection of abnormal pulmonary mechanics in SSc.'5 16 Few reports2 13 exist on the relation between lung compliance and TLCO in SSc.
The purpose of this study was to assess the relation between abnormalities in TLCO and Cst in patients with SSc with early pulmonary disease and also to relate pulmonary disease to the degree of vascular abnormality, smoking habits, and skin disease.
Patients and methods
Fifty nine patients, 39 consecutive new cases admitted to the department and 20 follow up patients, were investigated for pulmonary disease. Forty eight patients fulfilled the American Rheumatism Association (ARA) criteria for SSc.'7 Seven patients had suspected SSc, with Raynaud's phenomenon and sclerodactyly, but not fulfilling the ARA criteria. Four patients had Raynaud's phenomenon without signs of a systemic connective tissue disease. Of the 48 patients with SSc, 37 had limited cutaneous systemic sclerosis-that is, skin disease restricted to the face, arms and legs, 18-and 1 1 had diffuse cutaneous systemic sclerosis with skin changes including the trunk.
The new patients had not been treated with disease modifying drugs but three were receiving glucocorticoids by mouth and one chloroquine. Six of the 20 follow up patients were treated with azathioprine, one with cyclophosphamide, and two with penicillamine. Seventeen patients were smokers; 13 of these had limited SSc, three had suspected SSc, and one had Raynaud's phenomenon only. Four patients, two with limited SSc and two with diffuse SSc, were anaemic with haemoglobin less than 115 g/l.
Vital capacity was measured with a dry spirometer and total lung capacity with body plethysmography. The elastic pulmonary properties were calculated from the oesophageal pressure as measured at different lung volumes. 9 Static elastic recoil pressure was recorded during flow interruptions covering most of the vital capacity. Static lung compliance was measured over the pressure interval 5-15 ml H20. Measurement of the transfer factor for carbon monoxide was made with the single breath method; a full vital capacity inhalation of a gas mixture containing Wilcoxon's test for paired data. Correlation between two variables was calculated with the Spearman's p value.
Results
The TLCO, vital capacity, total lung capacity, and Cst were decreased in the two SSc subgroups compared with predicted values (table 1) . No significant decrease was seen in seven patients with suspected SSc and in four patients with Raynaud's phenomenon only compared with the predicted values of vital capacity, total lung capacity, Cst, or TLCO, though there was a slight decrease in the TLCO (NS; p=009) in patients with suspected SSc.
Eleven of 48 patients with SSc (eight with limited and three with diffuse SSc) had a disease duration of 0-1 year (fig 1) . Seven of these 11 had a TLCO less than two standard deviations (SD), three had a vital capacity and total lung capacity less than 2 SD, and two had a Cst decreased by more than 2 SD. The eight patients with limited SSc had decreased TLCO (p<002) compared with the predicted values, whereas their vital capacity, total lung capacity, and Cst were not significantly low.
Nineteen patients, 12 12. patients and were unable to find any patient 
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with inflammatory change not accompanied by fibrosis. They suggested that a concomitant fibroblastic proliferation and an inflammatory reaction proceed from the earliest histologically identifiable stages. The lung function tests applied in the evaluation of patients with SSc reflect different aspects of the disease process. Measurement of static lung compliance is considered to give the most specific information about the mechanical properties of the lung tissue. Compliance is reduced by interstitial fibrosis, but also by oedema and cellular infiltration. Total lung capacity and vital capacity depend to a large extent on the mechanical properties of the lung, but also on the chest wall mechanics, the function of inspiratory muscles and the mechanical properties of the airways. The main determining factors for the TLCO are considered to be the available alveolar diffusion area, the diffusion path length (that is, the thickness of the alveolar-capillary barrier) and the available binding sites (depending on the haemoglobin concentration and the pulmonary capillary blood volume). The TLCO reflecting the function of the alveolar-capillary unit seems to be influenced by alveolitis3 5 and microvascular disease,'2 and markedly decreased TLCO values are found in patients with pulmonary hypertension.23 24 In the combined patient group we found a correlation between the TLCO and the vital capacity similar to that previously reported by Lewis et al. 27 In severe pulmonary disease of SSc lung compliance, and thereby lung volumes, are greatly reduced. In such patients the reduction of diffusion area can be expected to affect the TLCO, thus explaining the correlation. In patients with short disease duration we found no correlation between the TLCO and the vital capacity or Cst. In this instance the reduction in TLCO may be attributed more to an increased diffusion path length or decreased pulmonary capillary blood volume, or both. The result of this study supports an alveolitis or a microvascular disease, or both, preceding the restrictive lung disease in SSc.
Treatment with cyclophosphamide has been suggested to be effective in ameliorating pulmonary disease in SSc by Silver et al28 and by our group.29 This study emphasises the need for a trial of early aggressive therapeutic intervention in SSc at a time when there is not yet any sign of a restrictive lung disease.
